Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kite Pharma
Manufacturing
With ‘lessons learned,’ Kite preps for key CAR-T launch
Gilead's Kite is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
Fraiser Kansteiner
Apr 28, 2026 11:30am
BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters
Mar 30, 2026 10:00pm
Licensing deals, Nkarta CEO comments and more—Fierce Pharma Asia
Oct 24, 2025 8:30am
FDA removes barrier to CAR-Ts; move likely to boost uptake
Jun 27, 2025 11:14am
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am
Gilead's Kite taps Amgen alum as new global commercial head
Jan 16, 2025 10:14am
